GLP1R and metabolic dysfunction-associated steatotic liver disease: This year, Mantovani et al. published a systematic review providing data on the beneficial effect of GLP-1 receptor antagonists on the histological features of NAFLD, including steatosis, ballooning, and lobular inflammation, as well as on the resolution of NASH without worsening of fibrosis [158].